investments

criteria

Geography
  • Global
 
Development stage
  • Biopharmaceutical company; proof of concept
  • Consumer product; revenue generating
 
Operational profile
  • Talented management team
  • Established IP position and/or strong brand potential
 
Investment philosophy
  • We are an active investor and prefer to take a leading position during fund raising
  • We will co-invest in the right opportunities
  • We prefer to be active in the Board of Directors
 
Security types
  • Equity
  • Convertible loans
 
Investment amount
  • Up to $50 million over the investment lifetime
  • No limit for buy-outs
  • Preferred initial investment of $8-10 million
Steve Orndorff, Accera
Steve Orndorff, Accera:
"Inventages provided critical funding to enable a Phase II clinical trial that met the highest standards of the FDA." More...